{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:22:00Z","timestamp":1793305320329,"version":"4.5.0"},"reference-count":22,"publisher":"Begell House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Long Term Eff Med Implants"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Dental implants offer a reliable solution for tooth replacement, but peri-implant diseases, especially peri-implantitis, jeopardize long-term success by causing inflammation and bone loss. Mechanical debridement is the primary treatment, though its effectiveness is limited by the complex implant surface. Adjunct therapies, particularly natural bioactive compounds, like thymoquinone from &lt;i&gt;Nigella sativa&lt;\/i&gt;, have shown promise in improving treatment outcomes due to their antimicrobial, anti-inflammatory, and regenerative properties. The aim of this study was to assess the clinical efficacy of locally applied thymoquinone gel combined with mechanical debridement in treating peri-implantitis. This prospective study included 40 participants with peri-implantitis, randomized into two groups. Group 1 received mechanical debridement alone, while Group 2 received debridement with 0.2&amp;#37; thymoquinone gel. Clinical parameters, including plaque index (PI), gingival index (GI), peri-implant probing depth (PPD), and clinical attachment level (CAL), were measured at baseline and after 3 months. Statistical analysis was performed using paired and independent &lt;i&gt;t&lt;\/i&gt;-tests. At the 3-month follow-up, Group 2 showed significantly better outcomes in PI (0.50 &amp;#177; 0.20), GI (0.62 &amp;#177; 0.11), PPD (3.02 &amp;#177; 0.14 mm), and CAL (3.17 &amp;#177; 0.31 mm) compared to Group 1 (&lt;i&gt;p&lt;\/i&gt; &amp;#60; 0.05). Thymoquinone gel as an adjunct to mechanical debridement significantly improves peri-implantitis management, offering a promising therapeutic option. Further studies with longer follow-up are needed to confirm its long-term effectiveness.\n<\/p>","DOI":"10.1615\/jlongtermeffmedimplants.2025058363","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:17:51Z","timestamp":1744802271000},"page":"37-43","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Potential of Thymoquinone in Conjunction with Mechanical Debridement for Peri-Implantitis: A Prospective Clinical Evaluation"],"prefix":"10.1615","volume":"35","author":[{"given":"Arunraaj","family":"Thanasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvina","family":"Rajasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Klinge B, Klinge A, Bertl K, Stavropoulos A. Peri-implant diseases. Eur J Oral Sci. 2018;126:88-94.","DOI":"10.1111\/eos.12529"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Rajasekar A, Varghese SS. Bacterial profile associated with peri-implantitis: A systematic review. J Long-Term Effects Med Implants. 2023;33(3):9-20. doi: 10.1615\/JLongTermEffMedImplants.2022044320.","DOI":"10.1615\/JLongTermEffMedImplants.2022044320"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Rajasekar A, Varghese SS. Quantification of red complex microorganisms among patients with different surface-modified dental implants: A prospective clinical study. J Int Oral Health. 2023;15(6):523-30.","DOI":"10.4103\/jioh.jioh_183_23"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Nedumaran N, Ramamurthy J. Evaluation of C-reactive protein and interleukin-6 levels in periodontitis patients: An experimental study. World J Dent. 2024;15(9):772-6.","DOI":"10.5005\/jp-journals-10015-2470"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Shukri NM, Duraisamy R, Balasubramaniam A, Ganapathy D. Evaluation of implant and prosthesis survival rates based on crestal bone loss. J Long-Term Effects Med Implants. 2023;33(2):1-14. doi: 10.1615\/JLongTermEffMedImplants.2022041096.","DOI":"10.1615\/JLongTermEffMedImplants.2022041096"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kumar KM, Varghese S, Jayaraman S, Ganapathy D, Karobari MI. Comparative evaluation of gingival crevicular fluid sulfiredoxin levels in patients with periodontitis prior and after periodontal therapy: A prospective clinical trial. World J Dent. 2024;15(5):394-400.","DOI":"10.5005\/jp-journals-10015-2400"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dreyer H, Grischke J, Tiede C, Eberhard J, Schweitzer A, Toikkanen SE, Gl\u00c3\u00b6ckner S, Krause G, Stiesch M. Epidemiology and risk factors of peri-implantitis: A systematic review. J Periodont Res. 2018;53(5):657-81.","DOI":"10.1111\/jre.12562"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Muthukuru M, Zainvi A, Esplugues EO, Flemmig TF. Non-surgical therapy for the management of peri-implantitis: A systematic review. Clin Oral Implants Res. 2012;23:77-83.","DOI":"10.1111\/j.1600-0501.2012.02542.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Roccuzzo A, De Ry SP, Sculean A, Roccuzzo M, Salvi GE. Current approaches for the non-surgical management of peri-implant diseases. Curr Oral Health Rep. 2020;7:274-82.","DOI":"10.1007\/s40496-020-00279-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Barbato L, Cavalcanti R, Rupe C, Scartabelli D, Serni L, Chambrone L, Cairo F. Clinical efficacy of adjunctive methods for the non-surgical treatment of peri-implantitis: A systematic review and meta-analysis. BMC Oral Health. 2023;23(1):375.","DOI":"10.1186\/s12903-023-03058-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Duraisamy R, Ganapathy D, Shanmugam R, Thangavelu L. Systematic review on hydroxyapatite and chitosan combination-coated titanium implants on osseointegration. World J Dent. 2024;15(1):79-86.","DOI":"10.5005\/jp-journals-10015-2358"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Darakhshan S, Pour AB, Colagar AH, Sisakhtnezhad S. Thymoquinone and its therapeutic potential. Pharmacol Res. 2015;95:138-58.","DOI":"10.1016\/j.phrs.2015.03.011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"AlAttas SA, Fat'Heya MZ, Turkistany SA. Nigella sativa and its active constituent thymoquinone in oral health. Saudi Med J. 2016;37(3):235.","DOI":"10.15537\/smj.2016.3.13006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, Chen S, Cochran D, Derks J, Figuero E, H\u00c3\u00a4mmerle CH. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89:S313-18.","DOI":"10.1002\/JPER.17-0739"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kapil H, Suresh DK, Bathla SC, Arora KS. Assessment of clinical efficacy of locally delivered 0.2% thymoquinone gel in the treatment of periodontitis. Saudi Dent J. 2018;30(4):348-54.","DOI":"10.1016\/j.sdentj.2018.06.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Farkhondeh T, Samarghandian S, Shahri AM, Samini F. The neuroprotective effects of thymoquinone: A review. Dose-Response. 2018;16(2):1559325818761455.","DOI":"10.1177\/1559325818761455"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Al-Khalifa KS, AlSheikh R, Al-Hariri MT, El-Sayyad H, Alqurashi MS, Ali S, Bugshan AS. Evaluation of the antimicrobial effect of thymoquinone against different dental pathogens: An in vitro study. Molecules. 2021;26(21):6451.","DOI":"10.3390\/molecules26216451"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Bhavikatti SK, Zainuddin SL, Ramli RB, Nadaf SJ, Dandge PB, Khalate M, Karobari MI. Insights into the antioxidant, anti-inflammatory and anti-microbial potential of Nigella sativa essential oil against oral pathogens. Sci Rep. 2024;14(1):11878.","DOI":"10.1038\/s41598-024-62915-1"},{"key":"20","unstructured":"Tawfig A. The effect of Nigella sativa extracts against Porphyromonas gingivalis isolated from periodontitis patients. Eur Rev Med Pharmacol Sci. 2023;27(21)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Ozdemir HA, Kara MI, Erciyas K, Ozer HA, Ay S. Preventive effects of thymoquinone in a rat periodontitis model: A morphometric and histopathological study. J Periodont Res. 2012;47(1):74-80.","DOI":"10.1111\/j.1600-0765.2011.01406.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Tada A, Nakayama-Imaohji H, Yamasaki H, Elahi M, Nagao T, Yagi H, Ishikawa M, Shibuya K, Kuwahara T. Effect of thymoquinone on Fusobacterium nucleatum\u00e2\u0080\u0093associated biofilm and inflammation. Mol Med Rep. 2020;22(2):643-50.","DOI":"10.3892\/mmr.2020.11136"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Marchetti E, Monaco A, Procaccini L, Mummolo S, Gatto R, Tet\u00c3\u00a8 S, Baldini A, Tecco S, Marzo G. Periodontal disease: The influence of metabolic syndrome. Nutr Metabol. 2012;9:1-3.","DOI":"10.1186\/1743-7075-9-88"}],"container-title":["Journal of Long-Term Effects of Medical Implants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/50642f5d6d39d94b\/JLT-58363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:33:19Z","timestamp":1752852799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/1bef42082d7a0fdf,1a2841753be9f164,50642f5d6d39d94b.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/jlongtermeffmedimplants.2025058363","relation":{},"ISSN":["1050-6934"],"issn-type":[{"value":"1050-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}